Posted 10/29/2019 12:14 AM (GMT 0)
I’m just browsing through different articles on IBD news and thought that you might find some of them interesting:
1. http://www.microbiometimes.com/researchers-unlock-potential-to-use-crispr-to-alter-the-microbiome/
Researchers at Western University have developed a new way to deliver the DNA-editing tool CRISPR-Cas9 into microorganisms in the lab, providing a way to efficiently launch a targeted attack on specific bacteria.
2. http://www.microbiometimes.com/bacteria-can-be-used-to-heal-aspirin-induced-ulcers-irish-research-reveals/
‘A remarkable first-of-its-kind study from Cork reveals that bifidobacteria can prevent aspirin-induced intestinal ulcers in humans.’
‘ Bifidobacterium breve Bif195 protects against small-intestinal damage caused by acetylsalicyclic acid in healthy volunteers ‘
3. https://ibdnewstoday.com/2019/09/20/innovation-planning-first-clinical-trial-of-oral-brilacidin-as-uc-treatment/
4. http://www.microbiometimes.com/finch-therapeutics-raises-53-million-to-advance-microbiome-based-therapies-for-recurrent-c-difficile-autism-and-other-disease-area
5. http://www.microbiometimes.com/poo-transplants-to-help-save-koalas/
6. https://ibdnewstoday.com/2019/08/07/edinburgh-one-of-highest-rates-ibd-world-study/
7. https://ibdnewstoday.com/2019/08/28/walnuts-may-protect-against-ulcerative-colitis-mice-study-suggests/
8. https://ibdnewstoday.com/2019/08/19/smoking-does-not-have-beneficial-effects-for-people-with-ulcerative-colitis/
9. https://ibdnewstoday.com/2019/08/23/landos-biopharma-secures-60-million-financing-continues-bt-11-development-ibd/
10. https://ibdnewstoday.com/2019/07/24/innovation-and-alfasigma-ink-pact-to-develop-and-commercialize-brilacidin-for-types-of-ibd/